Imaging features | Univariate analysis for subtype | Multivariate analysis for subtype | ||||
---|---|---|---|---|---|---|
p value | OR | 95% CI | p value | OR | 95%CI | |
Intratumoral hemorrhage | 0.448 | 2.179 | 0.292-16.266 | |||
Restricted diffusion | NA | NA | NA | |||
Targetoid restriction | 0.002* | 0.159 | 0.050-0.508 | 0.008* | 0.079 | 0.012-0.520 |
Arterial phase hypoenhancement | 0.003* | 8.571 | 2.118-34.688 | 0.028* | 8.186 | 1.257-53.287 |
Rim APHE | 0.058 | 0.813 | 0.162-1.032 | |||
Non-rim APHE | 0.497 | 0.654 | 0.192-2.228 | |||
Targetoid appearance in T2 | 0.006* | 0.116 | 0.025-0.532 | 0.083 | 0.141 | 0.015-1.294 |
Peripheral washout | 0.087 | 0.356 | 0.109-1.162 | |||
Non-peripheral washout | 0.413 | 0.400 | 0.045-3.584 | |||
Delayed enhancement | 0.901 | 1.083 | 0.305-3.847 | |||
Corona enhancement | 0.223 | 0.553 | 0.197-1.434 | |||
Enhancing capsule | 0.707 | 0.764 | 0.188-3.112 | |||
Tumor in vein | 0.026* | 4.489 | 1.200-16.798 | 0.606 | 0.582 | 0.074-4.567 |
Intrahepatic duct dilatation | < 0.001* | 15.532 | 5.8343-45.156 | < 0.001* | 37.500 | 6.985-201.329 |
Hepatic capsule retraction | 0.395 | 0.679 | 0.278-1.657 |